Patent · US Active

Glucose sensor apparatus addressing interference of ascorbic acid and acetaminophen

US10327684B2 · kind B2 · utility

0Cited by
6References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2017
Grant dateJun 25, 2019
Priority date—
Expiry dateDec 27, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/92
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

This disclosure relates to a nanoporous composition including a number of clusters of nanoparticles dispersed in a liquid, a nanoporous layer formed of the nanoporous composition, a glucose-oxidation electrode including the nanoporous layer, and a glucose-sensing device and system including the glucose-oxidation electrode. This disclosure also relates to a method of making the nanoporous composition, the nanoporous layer, the glucose-oxidation electrode and the glucose-sensing device and system. Further, this disclosure also relates to devices, systems and methods for continuous glucose monitoring (CGM) and blood glucose monitoring (BGM).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.